{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
glutathione disulfide
to a specific field?
Status:
Designated
Source:
FDA ORPHAN DRUG:516316
Source URL:
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
Other
Class:
MIXTURE
Status:
US Previously Marketed
Source:
PITRESSIN TANNATE by PARKE DAVIS
(1941)
Source URL:
First approved in 1941
Source:
PITRESSIN TANNATE by PARKE DAVIS
Source URL:
Class:
MIXTURE
Status:
US Approved Rx
(2025)
Source:
BLA761394
(2025)
Source URL:
First approved in 2025
Source:
BLA761394
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761369
(2024)
Source URL:
First approved in 2024
Source:
BLA761369
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761365
(2024)
Source URL:
First approved in 2024
Source:
BLA761365
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2024)
Source:
BLA761248
(2024)
Source URL:
First approved in 2024
Source:
BLA761248
Source URL:
Class:
PROTEIN
